Invention Grant
- Patent Title: Cancer treatment and immune system regulation through FAT10 pathway inhibition
-
Application No.: US14390265Application Date: 2013-04-02
-
Publication No.: US09637740B2Publication Date: 2017-05-02
- Inventor: Yifat Merbl , Marc W. Kirschner
- Applicant: President and Fellows of Harvard College
- Applicant Address: US MA Cambridge
- Assignee: President and Fellows of Harvard College
- Current Assignee: President and Fellows of Harvard College
- Current Assignee Address: US MA Cambridge
- Agency: Foley Hoag LLP
- International Application: PCT/US2013/034950 WO 20130402
- International Announcement: WO2013/151999 WO 20131010
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/02 ; C07H21/04 ; C12N15/113 ; G01N33/50 ; A61K31/7105 ; A61K31/713 ; G01N33/68 ; A01K67/027 ; C07K14/00
Abstract:
Described herein are methods of inhibiting mitosis, treating cancer and/or treating immune disorders through the use of agents that inhibit FAT 10 and/or the FAT 10 pathway.
Public/Granted literature
- US20150322427A1 Cancer Treatment and Immune System Regulation Through FAT10 Pathway Inhibition Public/Granted day:2015-11-12
Information query
